$BIIB Biogen Idec, Inc. BIIB Company Overview
Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt1=Go!
Last Updated: Saturday, January 11, 2014 12:35:35 PM
Biogen Idec, Inc. BIIB Current Price and Quotes
Last Price 299.31
Previous Close
289.75
Open
291.57
Daily Range
299.85 - 286.30
52wk Range
298.82 - 139.72
Volume
1,868,748
Dividend
N/A
Average Vol (3m)
1,201,744
Yield
N/A
Biogen Idec, Inc. BIIB
Company Information
14 Cambridge Center
Cambridge, MA 02142
Website: http://www.idecpharm.com
Phone: (617) 679-2000
Biogen Idec, Inc. BIIB
Not Available
Biogen Idec, Inc. BIIB
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000875045
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Formerly=IDEC Pharmaceuticals Corp. until 11-03
Note=6-97 State of Incorporation California changed to Delaware
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Biogen Idec, Inc. BIIB
BIIB Security Details
Share Structure
Market Value1 $70,700,892,078 a/o Jan 10, 2014
Shares Outstanding 236,212,930 a/o Oct 21, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.0005
Shareholders
Shareholders of Record 2,912 a/o Feb 14, 2008
Security Notes
New Issue=9-91 3,000,000 shs at $15 by Montgomery Securities et al.
Latest Addt'l Issue=11-00 2,600,000 shs at $181.81 by Merrill Lynch & Co. et al.
Cap. Change=shs increased by 2 for 1 split. Ex-date=12-21-99. Rec. date=12-01-99. Pay. date=12-20-99
Capital Change=shs increased by 3 for 1 split. Ex-date=01/18/2000. Rec date=12/26/2000. Pay date=01/17/2001.
Short Selling Data
Short Interest 12,521,397 (6.96%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)
BNYMellon Shareowner Services
Biogen Idec, Inc. BIIB Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 5,516,461 5,048,634 4,716,423 4,377,348
Cost of Revenue 545,494 466,780 400,262 382,104
Gross Profit 4,970,967 4,581,854 4,316,161 3,995,244
Operating Expenses
Research and Development 1,334,919 1,219,602 1,248,604 1,283,068
Sales, General and Admin. 1,622,562 1,409,969 1,289,611 1,126,938
Non-Recurring Items 2,225 19,026 320,129 -
Other 202,204 208,566 208,928 289,811
Operating Income 1,855,849 1,724,691 1,248,889 1,295,427
Income From Continuing Operations
Add'l Income/Expense Items 46,048 (13,477) (18,983) 37,252
Earnings Before Interest and Tax 1,901,897 1,711,214 1,229,906 1,332,679
Interest Expense - - - -
Earnings Before Tax 1,901,897 1,711,214 1,229,906 1,332,679
Income Tax 470,554 444,528 331,333 355,617
Minority Interest - 32,258 (106,700) 6,930
Equity Earnings Unconsolidated Subsidiary (4,518) - - -
Net Income Cont. Operations 1,426,825 1,234,428 1,005,273 970,132
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,380,033 1,234,428 1,005,273 970,132
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,380,033 1,234,428 1,005,273 970,132
Biogen Idec, Inc. BIIB Recent News
Jan 9, 2014 Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies
Jan 9, 2014 Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Jan 9, 2014 Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs
Jan 8, 2014 The Zacks Analyst Blog Highlights:FedEx, Alkermes, Biogen Idec, Perrigo and BioMarin Pharmaceutical
Jan 7, 2014 Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 7, 2014 Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA
Jan 2, 2014 Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Dec 31, 2013 Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma
Dec 23, 2013 Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna
Dec 17, 2013 WCG Hires Adam Cohen, Digital Thought Leader, to Strengthen Technology Practice
12345next >
BIIB Biogen Idec, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BIIB/quote
Stock Chart http://www.otcmarkets.com/stock/BIIB/chart
Company Info http://www.otcmarkets.com/stock/BIIB/company-info
Recent News http://www.otcmarkets.com/stock/BIIB/news
Financials http://www.otcmarkets.com/stock/BIIB/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BIIB/filings
Short Sales http://www.otcmarkets.com/stock/BIIB/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BIIB/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BIIB/research
Summary http://finance.yahoo.com/q?s=BIIB
Historical Prices http://finance.yahoo.com/q/hp?s=BIIB+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BIIB
Basic Chart http://finance.yahoo.com/q/bc?s=BIIB+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIIB+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BIIB+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BIIB+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BIIB+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BIIB+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BIIB+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BIIB+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BIIB+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BIIB+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BIIB
Balance Sheet http://finance.yahoo.com/q/bs?s=BIIB
Cash Flow http://finance.yahoo.com/q/cf?s=BIIB+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BIIB
Market Watch http://www.marketwatch.com/investing/stock/BIIB
Bloomberg http://www.bloomberg.com/quote/BIIB:US
Morningstar http://quotes.morningstar.com/stock/s?t=BIIB
Bussinessweek http://investing.businessweek.com/research/st...icker=BIIB
Barchart http://www.barchart.com/quotes/stocks/BIIB
OTC Short Report http://otcshortreport.com/index.php?index=BIIB
Investopedia http://www.investopedia.com/markets/stocks/BIIB/?wa=0
Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt1=Go!
Last Updated: Saturday, January 11, 2014 12:35:35 PM
Biogen Idec, Inc. BIIB Current Price and Quotes
Last Price 299.31
Previous Close
289.75
Open
291.57
Daily Range
299.85 - 286.30
52wk Range
298.82 - 139.72
Volume
1,868,748
Dividend
N/A
Average Vol (3m)
1,201,744
Yield
N/A
Biogen Idec, Inc. BIIB
Company Information
14 Cambridge Center
Cambridge, MA 02142
Website: http://www.idecpharm.com
Phone: (617) 679-2000
Biogen Idec, Inc. BIIB
Not Available
Biogen Idec, Inc. BIIB
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000875045
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Formerly=IDEC Pharmaceuticals Corp. until 11-03
Note=6-97 State of Incorporation California changed to Delaware
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Biogen Idec, Inc. BIIB
BIIB Security Details
Share Structure
Market Value1 $70,700,892,078 a/o Jan 10, 2014
Shares Outstanding 236,212,930 a/o Oct 21, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.0005
Shareholders
Shareholders of Record 2,912 a/o Feb 14, 2008
Security Notes
New Issue=9-91 3,000,000 shs at $15 by Montgomery Securities et al.
Latest Addt'l Issue=11-00 2,600,000 shs at $181.81 by Merrill Lynch & Co. et al.
Cap. Change=shs increased by 2 for 1 split. Ex-date=12-21-99. Rec. date=12-01-99. Pay. date=12-20-99
Capital Change=shs increased by 3 for 1 split. Ex-date=01/18/2000. Rec date=12/26/2000. Pay date=01/17/2001.
Short Selling Data
Short Interest 12,521,397 (6.96%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)
BNYMellon Shareowner Services
Biogen Idec, Inc. BIIB Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 5,516,461 5,048,634 4,716,423 4,377,348
Cost of Revenue 545,494 466,780 400,262 382,104
Gross Profit 4,970,967 4,581,854 4,316,161 3,995,244
Operating Expenses
Research and Development 1,334,919 1,219,602 1,248,604 1,283,068
Sales, General and Admin. 1,622,562 1,409,969 1,289,611 1,126,938
Non-Recurring Items 2,225 19,026 320,129 -
Other 202,204 208,566 208,928 289,811
Operating Income 1,855,849 1,724,691 1,248,889 1,295,427
Income From Continuing Operations
Add'l Income/Expense Items 46,048 (13,477) (18,983) 37,252
Earnings Before Interest and Tax 1,901,897 1,711,214 1,229,906 1,332,679
Interest Expense - - - -
Earnings Before Tax 1,901,897 1,711,214 1,229,906 1,332,679
Income Tax 470,554 444,528 331,333 355,617
Minority Interest - 32,258 (106,700) 6,930
Equity Earnings Unconsolidated Subsidiary (4,518) - - -
Net Income Cont. Operations 1,426,825 1,234,428 1,005,273 970,132
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,380,033 1,234,428 1,005,273 970,132
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,380,033 1,234,428 1,005,273 970,132
Biogen Idec, Inc. BIIB Recent News
Jan 9, 2014 Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies
Jan 9, 2014 Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Jan 9, 2014 Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs
Jan 8, 2014 The Zacks Analyst Blog Highlights:FedEx, Alkermes, Biogen Idec, Perrigo and BioMarin Pharmaceutical
Jan 7, 2014 Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 7, 2014 Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA
Jan 2, 2014 Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Dec 31, 2013 Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma
Dec 23, 2013 Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna
Dec 17, 2013 WCG Hires Adam Cohen, Digital Thought Leader, to Strengthen Technology Practice
12345next >
BIIB Biogen Idec, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BIIB/quote
Stock Chart http://www.otcmarkets.com/stock/BIIB/chart
Company Info http://www.otcmarkets.com/stock/BIIB/company-info
Recent News http://www.otcmarkets.com/stock/BIIB/news
Financials http://www.otcmarkets.com/stock/BIIB/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BIIB/filings
Short Sales http://www.otcmarkets.com/stock/BIIB/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BIIB/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BIIB/research
Summary http://finance.yahoo.com/q?s=BIIB
Historical Prices http://finance.yahoo.com/q/hp?s=BIIB+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BIIB
Basic Chart http://finance.yahoo.com/q/bc?s=BIIB+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIIB+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BIIB+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BIIB+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BIIB+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BIIB+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BIIB+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BIIB+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BIIB+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BIIB+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BIIB
Balance Sheet http://finance.yahoo.com/q/bs?s=BIIB
Cash Flow http://finance.yahoo.com/q/cf?s=BIIB+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BIIB
Market Watch http://www.marketwatch.com/investing/stock/BIIB
Bloomberg http://www.bloomberg.com/quote/BIIB:US
Morningstar http://quotes.morningstar.com/stock/s?t=BIIB
Bussinessweek http://investing.businessweek.com/research/st...icker=BIIB
Barchart http://www.barchart.com/quotes/stocks/BIIB
OTC Short Report http://otcshortreport.com/index.php?index=BIIB
Investopedia http://www.investopedia.com/markets/stocks/BIIB/?wa=0
